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The purpose of the study
• With the rise of the human lifespan has come the rise of age-related
disorders, particularly neurodegenerative diseases that express
themselves late in life such as Alzheimer’s disease (AD) and
Parkinson’s disease (PD)
• However, age-related diseases also means more research spending in cancer
treatments

• The paper seeks to (1) evaluate the role of molecular genetics in
research studies and (2) examine the use of D. melanogaster (the
common fruit fly)

Introduction
• Medical problems such as Parkinson’s disease pose a problem for
both the individuals diagnosed with the diseases and those who have
to take care of the affected individual
Stress for the
individual

Stress for the family

Take up hospital beds

Stress for primary and
secondary care takers

More tax paper money
for governmentally
funded hospitals and
health care systems

Introduction
• These stressors necessitate government involvement through
research.
• These research programs take up money that could be spent toward other
programs such as Social Security and employee benefits
• The private sector could be delegated the task of conducting research
• However, this may mean fewer treatments for patients and less novelty in
daily life

• Discussion question: Regarding research, are you happy with the
government’s allocation of money? Should the government change
the amount of spending it is putting towards research?

Introduction
• Before testing on human subjects, research is largely conducted on
less-expensive and lower-risk species such as mice that mimic the
human genome
• However, genetic engineering has also allowed us to edit the
genomes of these species and mimic the conditions in individuals
with altered genes (like in individuals with genetically-linked diseases)

Molecular genetics and the diversification of
animal model organisms
• Besides the costs and ethical dilemmas, there are two main reasons
why using animals with germ lines similar to those of humans is
useful
• When the genome of these species is unaltered, they allow us to test whether
various chemicals or treatments are useful to regular people
• When their genomes are edited, they allow us to mimic patients with
preexisting conditions

• The latter has been made possible through genetic engineering

Molecular genetics and the diversification of
animal model organisms
• Method 1: The use of recombinant DNA to splice DNA fragments into
bacteria using plasmids and viral vectors

Molecular genetics and the diversification of
animal model organisms
• Bacteria are single-celled organisms
• Method 2: The introduction of genetic engineering into single-celled
species paved the way for the introduction of genetic engineering into
multicellular organisms and ultimately humans
• The transgenic approach was introduced into mice in the early 1980s
and eventually fruit flies later on
• These animal models have been instrumental in studying the
neurodegenerative effects of Alzheimer’s, Parkinson’s, ALS, and
Huntington’s disease

Molecular genetics and the diversification of
animal model organisms
• Method 3: Genome sequencing allowed researchers to take a look at
the genomes of various animals species such as nematodes and mice
• This allows researchers to determine animal counterparts to humans
that can fit within their realm of study
• Genome sequencing also reveals the degree to which genes have
been preserved over the course of evolution
• Not only is the structure of the resulting proteins the same but also their
function in those organisms

• This further affirms the use of animal models as human alternatives

Molecular genetics and the diversification of
animal model organisms
• Method 4: Come up with DNA probes that can quantify the
expression of certain genes in different organisms
• Even though we may share many of the same genes as mice (99%
similarity), mice definitely express different genes that we do, leading
to their different physiology and responses to treatments
• What this means is that animals cannot be the end-all-be-all of drug
testing: human trials are required

Advantages and purpose of simpler
organisms
• Simpler human alternatives have the following advantages:
•
•
•
•
•
•

They are genetically similar to humans
They do not pose as many ethical dilemmas (especially simpler organisms)
They are less expensive to maintain
Animals reproduce more often
They produce more offspring
They are more freely available

• However, animal models also have various disadvantages

Advantages and purpose of simpler
organisms
• Disadvantages of animal models
•
•
•
•
•

They do not perfectly mirror the human genome
Some species (such as pigs) still pose ethical dilemmas
At a large scale, high costs up-front
High personal effort on the part of researchers (mice will not maintain themselves)
The integration of animal models in research means that there are more barriers in
introducing a new treatment to the public

• What side does the author err on?
•
•
•
•

The author would suggest that the advantages outweigh the disadvantages
With similar genomes, similar responses to treatments are ensured
Animal testing is required for human approval
They provide more in-depth insight as you can cut them up and observe them
without ethical issues

Drosophila melanogaster as a model organism of
choice to study neurodegenerative diseases
• So, animal models are effective
• Now, what animal should you use for neurodegenerative disorders?
• Mice have complex nervous systems, but they can pose ethical
dilemmas and cost more to maintain and test on
• D. melanogaster has nerve cells exposed (eye), but they are difficult
observe in vivo
• Nematodes are simple organisms, but they have primitive nervous
systems

Drosophila melanogaster as a model organism of
choice to study neurodegenerative diseases
Mouse

Fruit Fly

Nematode

• Most expensive to
maintain and examine
• Difficult to manage
• Pose ethical dilemmas
• Complex nervous
systems (70 million
neurons)

• Easy to maintain
• Eyes can be examined
for neurodegeneration
• Do not pose ethical
dilemmas
• Relatively simple
nervous systems
(200,000 neurons)

• Easy to maintain and
purchase
• Easy to genetically
modify
• Do not pose ethical
dilemmas
• Very simple nervous
systems (302 neurons)

Drosophila melanogaster as a model organism of
choice to study neurodegenerative diseases
• Upon other advantages, D. melanogaster has several benefits over
other organisms in modeling neurodegenerative diseases
• Easy to reproduce
• Many offspring
• ”At least 77% of the human disease-associated genes reported in the Online
Mendelian Inheritance in man database have evolutionary similarities with
Drosophila genes”

Drosophila and the study of
neurodegeneration
• Fruit flies have been used for over 100 years in biological research, so
they have a proven track record for use in research
• Benzer et al. conducted the first studies with fruit flies
• Since then, 4 approaches have been developed to study fruit flies in
regard to neurodegeneration

Drosophila and the study of
neurodegeneration
• Method 1: Isolating genes and mutations that lead to
neurodegeneration (“forward screens”)
• Change up the phenotype (use different individuals) and observe
which gene was making the difference
• RNA interference (RNAi) has allowed researchers to disrupt D.
melanogaster genomes and observe which genes lead to maladaptive
effects

Drosophila and the study of
neurodegeneration
• Method 2: ”reverse screens”
• Alter the genotype, and observe the phenotype
• CRISPR/Cas9 can be used to edit the genome on a large scale with
extreme precision
• This would only be ethical in simple organisms, however
• Discussion Question: Do you think that reverse screens would be
ethical in humans? What about the prospects of CRISPR/Cas9 serving
as a tool for making designer babies?

Drosophila and the study of
neurodegeneration
• Method 3: Studying the fly’s eye
• D. melanogaster has a large, repetitive visual receptor array
influenced by the health of feeding neurons
• If the visual receptors are altered, they can be observed and a
“rough” appearance to the eye is common

Drosophila and the study of
neurodegeneration
• Method 4: Using enhancer-suppressor modifier genes
• Some genes are directly linked to certain phenotypes such as nerve
toxicity
• However, other genes control the expression of the mutated genes,
leading to higher or lower expression
• Altering or removing the modifier gene can increase or decrease the
severity of a condition, or make the expression of the first gene out of
control
• Inference: fighting tumorigenic modifier genes could serve as a
disease-modifying treatment for cancer

What has been found using Drosophila?
• Forward screens of the fruit fly genome have found over 40 genes to
the “recessive loss of functions” (like AD and PD)
• More than half of these genes have been found to be linked to
neurodegeneration
• “This list underestimates the actual number of genes whose mutation
may lead to a loss of integrity or function of the fly nervous system.”
• Evidence has shown that mutations of the parkin and pink1 genes are
associated with PD

What has been found using Drosophila?
• One functional screen on the D. melanogaster genome has examined
87 loss-of-function genes linked to Alzheimer's and found several
modifier genes, including some that alter the presence of the Tau
protein (leads to neurodegeneration through the amyloid-β peptide)
• In vivo studies in D. melanogaster have shown a linkage in APP (a
precursor to the amyloid protein) and neuroanatomical defects linked
to Alzheimer’s
• Recent news: Aducanumab has recently been approved as a
treatment for Alzheimer’s (June 7th)

What has been found using Drosophila?
• Fruit flies have also been used to identify
that exon 1 of the Huntington’s gene is
particularly pathogenic, making a potential
target for therapy
• Similar neurodegeneration as shown on the
left can be expected from the Huntington’s
gene

Future prospects for the fly model
(identify pathways that lead to
disease: the expression of X
gene leading to the production
of Y protein to lead to Z effect)

(potential application is isolating
the protein coming from the
identified gene and test whether it
has effects on humans or mice)

(generation of basic and applied
research designs to test the
involvement of the identified
gene in neurodegeneration)

(identify genetic targets for the
development of drugs designed
to deter the expression of the
gene in clinical studies)

Future prospects for the fly model
• My interpretation of the diagram prior to this slide
• First the genetic origin of a particular phenotype or disease can be tested in
D. melanogaster. Protective substances can also be tested for effectiveness
against neurodegeneration
• Secondly, studies in higher-order, mammalian organisms such as mice or rats
can be conducted
• Lastly, human trials can be conducted for effectiveness

Future prospects for the fly model
• Although the fly model most definitely is useful, it is not perfect
• Compared to humans, flies have relatively simple nervous systems, meaning
they are not dependable for direct translation into human research (mice
generally serve as the middle ground)
• Flies are arthropods while humans are vertebrates, marking a divergence in
evolution. Thus, the disease-linked genes in flies may not be causative factors
for neurodegeneration in humans

Future prospects of the fly model
• Although D. melanogaster differs from humans, it has a number of
benefits still
• Its genome has been thoroughly mapped
• The protective role of various chemicals can be examined
• Lithium use in fruit flies has been shown to suppress the accumulation of amyloid-β in
the Alzheimer’s model
• Methylene blue (a common staining tool) has been shown to lower neurodegeneration
in Huntington's’ patients
• A short peptide from Huttingtin has been shown to decrease the accumulation of the
polyglutamine protein in the fly HD model

• It is the best-analyzed and best understood multicellular organism to date

Summary
• Molecular genetics has played a powerful role in allowing us to
discover the effects of genetic mutations and conditions, as well as
identify animal models for treatment development in humans
• D. melanogaster serves as a promising human alternative for testing
in research trials

Discussion Questions
• Going back to the very reason for this study, diseases present
themselves late in life. While many are unavoidable (such as HD Type
II diabetes), many are avoidable. Should the government spend more
money trying to encourage healthy living habits or fund research to
produce treatments for avoidable diseases?
• Do you think that D. melanogaster serves as an adequate alternative
to human in vivo trials? Would mice models suffice in their place?
• One of the foundational tools in the review was the use of molecular
genetics. Do you think neurodegenerative diseases can be explained
in light of evolution (genetics), or are the result of the present
(modern medicine)?

Discussion Questions
• What do you think about the use of animal models in general? Is
there an alternative way to coming up with drugs and treatments that
does not involve harming animals?
• Based upon the findings in the review, what do you think would be
some good follow-up experiments that would benefit the larger
scientific community?
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